Glenmark gets 2nd FDA nod for high blood sugar drug
Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.
Drugs
Pharma
Health
Medical
Pharma
U.S. to end Covid-19 curbs on May 11, migrant policy remains same
The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.
Drugs
Pharma
Glenmark’s heart failure treatment drug makes India debut
Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.
Drugs
Pharma
USFDA grants ‘tentative approval’ to Zydus’ mental health drug
The USFDA has granted Zydus Lifesciences Limited ‘tentative approval’ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Drugs
Pharma
Eiasi files market authorization for Alzheimer’s drug in Japan
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs
Health
Pharma
Decade-long study pinpoints baffling causes of epilepsy in children
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure.
Drugs
Pharma
California sues insulin makers, PBMs, for skyrocketing prices
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs
Health
Pharma
Own bacteria may cause some infections in hospitals: Study
If you are in a hospital, then at times, you get bacterial infections from one source — yourself.
Drugs
Pharma
AstraZeneca to acquire US-based CinCor for $1.8 billion
AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.